J PHARMACOKINET PHAR 润色咨询

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

出版年份:2001 年文章数:701 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:16.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1099501, encodeId=a730109950167, content=讨论怎么写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099502, encodeId=4383109950202, content=引言和讨论之间有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    讨论怎么写?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1099501, encodeId=a730109950167, content=讨论怎么写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099502, encodeId=4383109950202, content=引言和讨论之间有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    引言和讨论之间有什么区别?

    1

    展开1条回复
共4条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分